# A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

> **NCT06736613** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma
- High-grade B-cell Lymphoma
- Stage III High Grade B-Cell Lymphoma
- Stage IV High Grade B-Cell Lymphoma
- DLBCL - Diffuse Large B Cell Lymphoma
- Intravascular Large B-Cell Lymphoma
- Diffuse Large B Cell Lymphoma of Breast
- Diffuse Large B Cell Lymphoma of Testis
- HIV-associated Diffuse Large B Cell Lymphoma
- Double Expressor DLBCL

## Interventions

- **DIAGNOSTIC_TEST:** Cerebral Spinal Fluid ctDNA

## Key facts

- **NCT ID:** NCT06736613
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2027-12-11
- **Final completion:** 2027-12-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736613, "A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06736613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*